US Drug Recall Register

FDA Drug Recalls

14,801 recalls, newest first

Class I · High risk Terminated

Smart Care HAND SANITIZER

Reason Labeling: Not Elsewhere Classified. Container packaging is made, formed or filled to be misleading, resembling food and drink pouches

Ashtel Studios, INC. NDC 70108-042-01 D-0098-2021
Class III · Low risk Terminated

Fluocinonide Ointment USP 0.05%

Reason Failed Impurities/Degradation - Out-of-specification results for Fluocinolone Acetonide impurity.

Teligent Pharma, Inc. NDC 52565-0040-15 D-0064-2021
Class I · High risk Terminated

Goldenseal POWDER

Reason Microbial Contamination of a Non-Sterile Product: Product tested positive for Cronobacter Sakazakii.

Wishgarden Herbs, Incorporated D-0220-2021
Class I · High risk Terminated

Cord Care POWDER

Reason Microbial Contamination of a Non-Sterile Product: Product tested positive for Cronobacter Sakazakii.

Wishgarden Herbs, Incorporated D-0219-2021
Class I · High risk Terminated

Happy Ducts Compress

Reason Microbial Contamination of a Non-Sterile Product: Product tested positive for Cronobacter Sakazakii.

Wishgarden Herbs, Incorporated D-0218-2021
Class III · Low risk Terminated

Nystatin Oral Suspension

Reason Failed Impurties/Degradation Specifications: out of specification results for an impurity for one lot

VistaPharm, Inc. NDC 66689-008-16 D-0019-2021
Class III · Low risk Terminated

Metformin Hydrochloride Tablets USP

Reason Presence of Foreign Tablets/Capsules: Metformin 1000mg with different imprint was found in bottles.

Legacy Pharmaceutical Packaging LLC NDC 68645-545-59 D-1626-2020
Class III · Low risk Terminated

Cystaran

Reason Subpotent Drug: Product testing identified a decreased level of the active ingredient, Cysteamine HCl.

Leadiant Biosciences, Inc. NDC 54482-020-01 D-0034-2021
Class II · Moderate risk Terminated

Riomet ER

Reason CGMP Deviations: Detection of N-nitrosodimethylamine (NDMA) impurity in finished drug product.

Sun Pharmaceutical Industries INC NDC 10631-019-17 D-0002-2021
Class III · Low risk Terminated

Homeopathic Energy Catalyst

Reason Labeling: Product Contains Undeclared API; Incorrect formulation

Grato Holdings, Inc. NDC 43742-0756-1 D-0099-2021
Class I · High risk Terminated

NP Thyroid 120

Reason Subpotent Drug: FDA analysis found these products to be less than the labeled claim for the levothyroxine (T4) portion of the product.

Acella Pharmaceuticals, LLC NDC 42192-328-01 D-0036-2021
Class I · High risk Terminated

NP Thyroid 15

Reason Subpotent Drug: FDA analysis found these products to be less than the labeled claim for the levothyroxine (T4) portion of the product.

Acella Pharmaceuticals, LLC NDC 42192-327-01 D-0035-2021
Class II · Moderate risk Terminated

Nature-Throid 1 GR

Reason CGMP deviations; repackaged product was recalled by the manufacturer because it was manufactured under the same conditions as products found to be sub-potent.

PD-Rx Pharmaceuticals, Inc. NDC 43063-819-01 D-0005-2021
Class III · Low risk Terminated

Nymalize

Reason Subpotent Drug

Arbor Pharmaceuticals Inc. NDC 24338-200-12 D-1625-2020
Class II · Moderate risk Terminated

Albuterol Sulfate Inhalation Aerosol

Reason Defective Delivery System: Sustained trend of failure to dispense complaints.

Perrigo Company PLC NDC 45802-088-01 D-1594-2020
Class II · Moderate risk Terminated

Phentermine

Reason cMGP Deviations: Drug products repackaged into pouches without supporting stability studies.

Calvin Scott & Company, Inc. NDC 00527-0597-10 D-0011-2021
Class II · Moderate risk Terminated

Diethylpropion

Reason cMGP Deviations: Drug products repackaged into pouches without supporting stability studies.

Calvin Scott & Company, Inc. NDC 00527-1477-01 D-0010-2021
Class II · Moderate risk Terminated

Diethylpropion

Reason cMGP Deviations: Drug products repackaged into pouches without supporting stability studies.

Calvin Scott & Company, Inc. NDC 00527-1475-01 D-0009-2021
Class I · High risk Terminated

M Hand Sanitizer Ethyl Alcohol Antiseptic 80%v/v

Reason Chemical Contamination and Subpotent Drug: FDA analysis found product to contain methanol and below label claim for ethanol.

Medek LLC D-1342-2022
Class III · Low risk Terminated

Citalopram Oral Solution

Reason Failed Impurities/Degradation Specifications; high out of specification results obtained at the 9 month stability timepoint

PAI Holdings, LLC. dba Pharmaceutical Associates Inc NDC 0121-1696-40 D-0015-2021
Class III · Low risk Terminated

Nicotine Gum

Reason Labeling: Incorrect or Missing Package Insert: The package insert included in the finished product is for the Canadian market and is not part of the current approved drug labeling.

P & L Developments, LLC NDC 11822-3328-3 D-0004-2021
Class II · Moderate risk Terminated

Buprenorphine Transdermal System 5 mcg/hour

Reason Failed Stability Specifications: Below specification result for buprenorphine release rate.

Teva Pharmaceuticals USA D-0003-2021
Class II · Moderate risk Terminated

Eye Itch Relief

Reason CGMP Deviations

Akorn, Inc. NDC 59779-920-01 D-1628-2020
Class II · Moderate risk Terminated

bio aaa Alcohol en Gel Antibacterial

Reason CGMP Deviations: Product manufactured in a facility where methanol was found in other distributed lots of product.

Ajr Trading LLC D-1620-2020